- Home
- RHI vs PTCT Comparison
RHI vs PTCT Comparison
Compare RHI & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RHI
- PTCT
- Stock Information
- Founded
- RHI 1948
- PTCT 1998
- Country
- RHI United States
- PTCT United States
- Employees
- RHI N/A
- PTCT N/A
- Industry
- RHI Professional Services
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- RHI Consumer Discretionary
- PTCT Health Care
- Exchange
- RHI Nasdaq
- PTCT Nasdaq
- Market Cap
- RHI 3.3B
- PTCT 5.3B
- IPO Year
- RHI N/A
- PTCT 2013
- Fundamental
- Price
- RHI $25.96
- PTCT $71.75
- Analyst Decision
- RHI Sell
- PTCT Buy
- Analyst Count
- RHI 7
- PTCT 17
- Target Price
- RHI $40.00
- PTCT $73.24
- AVG Volume (30 Days)
- RHI 2.6M
- PTCT 1.1M
- Earning Date
- RHI 10-22-2025
- PTCT 11-04-2025
- Dividend Yield
- RHI 9.07%
- PTCT N/A
- EPS Growth
- RHI N/A
- PTCT N/A
- EPS
- RHI 1.54
- PTCT 8.94
- Revenue
- RHI $5,458,499,000.00
- PTCT $1,779,150,000.00
- Revenue This Year
- RHI N/A
- PTCT $119.02
- Revenue Next Year
- RHI $0.90
- PTCT N/A
- P/E Ratio
- RHI $16.88
- PTCT $8.03
- Revenue Growth
- RHI N/A
- PTCT 97.54
- 52 Week Low
- RHI $25.22
- PTCT $35.95
- 52 Week High
- RHI $78.41
- PTCT $73.98
- Technical
- Relative Strength Index (RSI)
- RHI 23.42
- PTCT 72.03
- Support Level
- RHI $25.22
- PTCT $66.10
- Resistance Level
- RHI $26.29
- PTCT $69.88
- Average True Range (ATR)
- RHI 1.11
- PTCT 2.47
- MACD
- RHI -0.25
- PTCT 0.05
- Stochastic Oscillator
- RHI 11.91
- PTCT 72.70
About RHI Robert Half Inc.
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.